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Abstract:
Background:
Poly Cystic Ovary Syndrome and Pelvic Floor Dysfunction are reproductive diseases with comorbidities whose
novel relationship deserves further investigation.
Methods:
Levator Ani Muscle/Paravaginal Attachment was dissected from female Rhesus Macaque and subjected to tissue
dissociation. Cells were treated with serum level hormones E2, T, and DHT. PCR, ICC, and IHC were used, followed by
statistical analysis.
Results:

RNA analysis show differences in relative expression for endpoints ER, PR, AR, Ki-67, Col1A, and Vimentin. IHC
along with ICC showed expression and localization in vivo.
Conclusions:
A novel in vitro model was created from macaque Levator Ani Muscle/Paravaginal Attachment for Pelvic Floor
Dysfunction in Poly Cystic Ovary Syndrome women. Treatment of cells with androgens revealed a potential therapeutic
target and possible etiology of PFD in PCOS women.
Introduction:
Poly Cystic Ovary Syndrome (PCOS) is clinically diagnosed using the Rotterdam criteria with the presence of
hyperandrogenemia, poly cystic ovary/ovaries, and anovulation (1). Hyperandrogenism is defined as elevated serum
levels of free testosterone (T) leading to overexpression of androgen receptor (AR) (2-4). These elevated levels of T have
widespread effects such as deepening of voice, hirsutism, and acne (5). Androgens have long been known to be anabolic
drivers of muscle growth and strength (6). It stands to reason that overexpression of androgen receptor would cause
strengthening of muscles around the body such as those in the pelvic floor. Yet, the incidence rate for women with PCOS
having Pelvic Floor Dysfunction (PFD) symptoms, does not align with this reasoning (1, 7). Even with increased levels of
T, estrogen (E2) levels are usually found to be within normal ranges, with some cases having increased levels of E2 (8).
The increased levels are mostly commonly attributed to the presence of hyperandrogenemia, due to the aromatization
of T (9). The pelvic floor has been shown to be responsive to steroid hormones (10). The effects of Estrogen Receptor
(ER) have been the subject of scrutiny, with the discourse community divided between if it upregulates collagen content
or has no significant affect (10-15). Much of the debate has limited the role of AR in the regulation of collagen in the
pelvic floor. The weakening of the muscles and ligaments that constitute the pelvic floor are crucial in development of
Pelvic Floor Dysfunction (PFD) (16).
PFD and Pelvic Organ Prolapse (POP) is caused when the pelvic floor muscles and ligaments are weakened(1719). This weakening is not attributed to atrophy, and although menopause is a risk factor, it does not account for all
cases of PFD (14, 19-26). The role of the Levator Ani Muscle (LAM) and Paravaginal Attachment (PA) are of most
relevance (27-29). These tissues have been attributed to having the most important role in pelvic floor support and,
make up most of the pelvic floor(27, 28). They are also responsive to steroid hormones (10). Studies have been limited in
the manner by which they can study this novel relationship between PFD and PCOS. They have been required to use
imaging techniques or been confined to small biopsy samples of tissues that are not vital to pelvic floor support, such as
the vaginal wall (14, 18, 27-32). This is why establishing a relevant in vitro model is a necessary advancement for the
field. Stromal cells are the best target cell because of their role in maintenance of pelvic floor support, they express
receptors for the various steroid hormones, and their role in tissue remodeling during wound healing (31-38). To our
knowledge, fibroblasts from human pelvic floor tissue have never been isolated from these tissues because of the
difficulty associated with dissecting a large enough tissue sample from the LAM/PA. These studies were carried out at
the Oregon National Primate Research Center (ONPRC). Dr. Cecily Bishop has characterized a macaque model of PCOS
that allows access to these unique tissues (3). The rhesus macaque provide the best animal model for PFD (39), because
like women they have mostly upright posture, they give birth to an infant with a relatively large head resulting in
damage to the pelvic floor, and naturally display PFD with age.

The aim was to characterize expression and localization of these steroid receptors in these LAM and PA stromal
cells. It included observing the effects of androgens on collagen production and characterization of collagen deposition.
In order to do this, this novel in vitro method was first developed.
Materials and Methods:
Rhesus Macaque Samples:
A study done through the National Centers for Translational Research in Reproduction and Infertility (NCTRI),
subjected juvenile female macaque to testosterone (T) (3). The other treatment groups were out of the scope of this
current study. Juvenile macaques that had not undergone menarche were sedated using ketamine, and a small 1cm
incision was done on the left subscapular region of the of the upper back. A testosterone implant was placed
subcutaneously, and the incision was stitched closed. All procedures were done in a sterile field. Similar procedures
were taken for replacing the implants. Animal samples were also taken from miscellaneous necropsies in which,
macaques that were otherwise unassociated with any study were euthanized. Euthanization was done in a case by case
basis and was most often attributed to GI issues. Animal care was done by the department of comparative medicine
(DCM). Animal use was reviewed and approved by the ONPRC Institutional Animal Care and Use Committee.
Cell Culture:
Tissue obtained was done during scheduled necropsies for the mentioned NCTRI research grant headed by
Cecily Bishop. The reproductive tract was isolated and transported to the lab workstation in a Hanks Balanced Salt
Solution (Hanks) with HEBES added. LAM and PA were then dissected at the bench workstation and placed in a
DEMEM/F12 + 1% antibiotic/antimycotic solution. Tissue could be left in 4C in this solution for up to 24hrs and stromal
cells could still be isolated and viable. Tissue was then placed in a petri dish and was rinsed with Hanks in order to wash
away as much of the blood as possible. Tissue was then minced in the DEMEM/F12 + 1% solution until pieces were very
fine, ~1-2mm in diameter. Tissue was then placed in digestion solution in order to break fibroblasts free from their ECM
matrix. Three digestion solutions were made; ~10mL of DEMEM/F12 + 1% was placed in a sterile filter along with
collagenase type I at a concentration of about 2mg/ml. Dispase was added at about 80uL for every 10mL and was at a
concentration of 5U/mL. Tissue was vacuumed in an automatic pipettor and was placed in the first collagenase wash.
The digestion solution was then placed in water bath at 37C and was swirled every 5 minutes for 20min. The
supernatant was then placed in a separate tube and diluted 1:1 with growth medium containing 10% FBS, this is
important as it stops collagenase type I activity and prevents it from digesting the desired stromal cells. Cells were
strained twice through a 40um strainer; each digestion solution was treated the same and was collected in conical tube.
The collection of supernatants was then spun down and cells were resuspended in growth medium and plated to seed.
Cells were kept in incubator at 37C with 5% CO2. Cells were then treated with 10nM concentrations of steroid hormones
E2, E2+T, and E2+DHT at 60% confluence and with growth medium + 2% FBS.
RNA Analysis:
RNA was extracted at 100% confluence with Monarch RNA extraction kit from New England Biolabs. Real-Time
PCR was done on 6 target endpoints where mRNA levels were measured from in vitro cell lines. Each target was subject
to 4 treatment groups; control, E2, E2+T, and E2+DHT. The DHT group is important because it does not allow for
aromatization. This allows for the ER component to be eliminated. These groups were selected in order to mimic the in
vivo conditions present in PCOS women. Each treatment group had a total of 8 individual cell groups taken and grown
from 3 different monkeys. This was done in order to provide relevant statistical power. True statistical power was
beyond the resource means and would require subjecting a large amount of rhesus macaques to a single study, which is
not possible. A calculation done in order to calculate the needed sample size was a total of 116 with 58 in each group.
When comparing 4 independent study groups this number compounded and was completely unreasonable. Yet, this
study still provides clinical insight in which trends can be seen. 3 different rhesus macaques were taken in order to
provide a broader insight, if this was not done a single cell line divided into multiple lines could be biased. mRNA was
targeted for ERalpha (ERa), Progesterone Receptor (PGR), Androgen Receptor (AR), Ki-67, Collagen type I alpha (Col1A),

and Vimentin (VIM). mRNA was measured by cycle threshold values (Ct) in reference to S10 the ribosomal protein.
Target values were then plotted on their own standard curve and the results were calculated against S10 levels. S10 has
been a standard to use in creating standard curves because of its uniformity in cells and low reactivity. mRNA levels
were also corrected for Vimentin. Vimentin being a non-hormonally regulated structural protein, it is a marker of
proliferation and migration in fibroblasts. It is present in all mesenchymal derived cells and serves as an intermediate
filament protein. Providing another needed reference point.
Statistics:
A one-way ANOVA was run on each treatment group. Each treatment group for each individual target was subjected to
a Shapiro-Wilk test for normality and the each produced a normal distribution (P>.05). Each target group was subjected
to Levene’s test for equality of variance and was normalized to fit all assumptions needed to have statistically relevant
data. Results were subjected to Grubb’s test for outliers. Sample group means, standard deviation, and standard error
were all calculated.
Immunohistochemistry:
Immunohistochemistry (IHC) was done on paraffin embedded tissue blocks and OCT microwave embedded
frozen tissue blocks using a standard method (40). Paraffin samples were able to be processed in at room temperature
while frozen OCT blocks were done at 4C on the first day; then room temperature on the second day. Sections were cut
at 5 um and were mounted on charged slides. Antibodies for AR, Col1A, and Ki-67 were diluted to 1:40, 1: 400, and
1:400 respectively. Frozen sections were kept at -80 C for 48hrs to allow full adherence to the slide. They were then
subjected to microwave antigen retrieval and immediately fixed in paraformaldehyde 4%. Slides were subjected to
rinsing washes and blocked using 2% normal horse serum in 1% BSA. Avidin and biotin were blocked for independently
using Vector Labs avidin/biotin blocking kit. Antibodies were diluted in 1% BSA and were kept on slides overnight
(~16hrs) at 4C for binding. Signal enhancement was done using the ABC/DAB method with biotinylated secondary
antibodies diluted 1:200. Ready to use ABC complex peroxidase solution was placed on sections and allowed to bind for
at least 1hr.
Paraffin slides were signal enhanced using the mentioned method above. Antigen retrieval was done using a
citrate buffer solution at pH 6 in the pressure cooker at 15 psi for 7 minutes. Slides were then blocked for using 2%
normal goat serum and primary antibodies were allowed to bind overnight at 4C.
Pictures were taken using Zeiss microscope at 20X magnification.
Immunocytochemistry:
Cells that were being resuspended for passaging were subjected to chamber slides. An aliquot of resuspension
~100uL was placed in each individual chamber of the chamber slide. Growth medium with 10% FBS ~1 mL was placed in
each chamber. Slides were then placed in incubator at 37C with 5% CO2. Chamber slides were then fixed with 4%
paraformaldehyde for 10 min at (37C). Cells were rinsed with packed PBS (.01M) and incubated with Triton X 100 at 37C
for 30minutes. Triton is a permeabilization reagent which creates small holes in the membrane and allows for entrance
of antibodies. Cells were rinsed with packed PBS and blocked with 2% normal serum and incubated for 1hr. Primary
antibody was diluted and chamber slides were covered in parafilm and kept overnight at 4C to allow time for binding.
Cells were then rinsed with packet PBS and secondary antibody was added diluted 1:200 and incubated for 30min at
room temp. ABC ready to use solution was added and incubated for 30 min at room temp. DAB was mixed in DI water at
pH was 7.6. 30% Hydrogen peroxide ~27 uL was added to activate DAB and cells were incubated at room temp for 5min.
Chambers were removed and mounted with aqueous mounting medium and allowed to dry for ~2 hrs before cover
slipping.
Results:
mRNA Transcripts:
PGR was significantly elevated in all three treatment groups (p<.05). Expression of PGR was lower in the
presence of androgens (p=.08) (figure 1B). Ki-67 also seemed to be downregulated in the E2 group with slightly higher
expression when androgens were present, which were not significant (p>.05) (figure 1D). Vimentin also has similar

expression across all groups, with differences that are not significant (figure 1F). Col1a, ERa, and AR when corrected for
vimentin, yielded significant differences. Col1a was downregulated in the presence of androgens (p=.05) (Figure 2A). ERa
and AR yielded significance at the 90% CI, in which the presence of androgens also downregulated their relative
expression (p=.1) (figure 2 B&C). It seems that when androgens are present a trend towards downregulation occurs. The
DHT group saw similar trends at the T group, even without the aromatization component of androgens, the effects are
similar. Leading to the conclusion that the effects are most likely due to expression of the AR, not through ER.
Immunostaining:
Trichrome staining previously done on the LAM and PA reveals the connection between the two tissues. The
collagen matrix extends deep into the LAM and surrounds various groups of muscle cells/bundles. Fibroblasts are also
imbedded in the collagen matrix between the LAM muscle bundles. Staining for COL1A reveals that majority of the
collagen in the LAM is COL1A and majority if not all of it in the PA. Staining against AR shows that fibroblasts in the LAM
and PA are also positive for this receptor, and that a majority of these cells are positive. Also, an interesting feature is
the nature of ERa and ERb localization in the LAM and PA. ERa seems to be localized to the stromal cells themselves,
while ERb is only localized to the muscle cells. Staining done for Ki-67 shows the quiescent nature of these fibroblasts
with only a few positive cells in the pictured regions of interest. Showed for comparison is a picture of basal vaginal
epithelium on the same section that is also stained for Ki-67.
Immunocytochemistry:
Steroid receptor targets staining demonstrated expression and localization of the receptors in fibroblasts from
the LAM and PA. Fibroblasts were seen to express ER, AR, PR, and Ki-67 cells were also seen to stain positive. These
receptors are localized to the nucleus and were present in majority of the cells.
Discussion:
Fibroblasts are an adaptive cell type with a crucial role in the development of PFD in PCOS women. Thanks to
the resources at the ONPRC, an in vitro model was able to be developed from the LAM and PA. A useful model in
studying the novel relationship between PCOS and PFD. As was shown the response to androgens from these fibroblasts
is dynamic and can change cell nature. When exposed to androgens in culture fibroblasts tend to reduce their
production of Col1a. Col1a is an extremely important protein that provides flexibility and strength in the pelvic floor. The
Col1a deposition seems to be controlled by the expression of steroid receptors. In the presence of androgens T and DHT,
collagen production was downregulated. The similar findings for both the T and DHT group supports the evidence that
this is most likely an AR dependent function. The vimentin ratios provided a guide for what function the cell is
prioritizing. Fibroblast production of vimentin increases during proliferation and migration. The cells prioritize
proliferation and migration when androgens are present. The constant elevated levels of T in PCOS women are likely
causing the reduction in collagen deposition and compromised support. The role of proliferation also seems to point to
the likelihood of some fibrosarcoma. The role of androgens in cancers has been confirmed in other carcinomas (41). This
relationship in the pelvic floor deserves further study.
The inhibition of ERa points to some negative feedback from AR in response to elevated levels of androgens.
This coincides with the literature, that AR has a downregulatory effect on ER expression. When the vimentin ration of
these two receptors were done, they were also downregulated in the presence of androgens. ERa is a proposed upregulator of collagen deposition and its expression leads to inhibition of enzymatic degradation of collagens (13, 15). Its
downregulation in combination with collagen suppression, supports the case even further for androgen’s negative
effects. This prioritization of cellular proliferation leads to less expression of ERa and therefore less collagen. There are
also the effects of AR being downregulated by the presence of its own ligands. E2 upregulated AR and when in
combination with T and DHT, its expression compared to vimentin production was also downregulated. Again, the cell is
prioritizing production of intermediate filaments and structural cell proteins over extracellular components such as
steroid receptors.
PGR was upregulated in each of the treatment groups, and this is most attributed to the E2 present in each
group. PGR is known to be a E2 sensitive which is supported by the results; but it also has an inhibitory affect towards ER
(42). When T and DHT were present PGR seemed to be downregulated, although these were not significant (p>.05). The
presence of T and DHT does not cause a significant downregulation, this allows for higher expression of PGR. Expression
of PGR leads to suppression of ER and therefore less collagen production.

The immunostaining provided greater insight into the specific type of collagen being produced. The over 10
forms of collagen make it difficult to predict what exactly is being deposited by these fibroblasts. The staining for Col1a
demonstrated that majority of the PA and LAM are made up Col1a. Staining for Ki-67 was not extremely proliferative in
the LAM and PA. The fibroblasts may be prioritizing intracellular components, but not DNA synthesis. Previous literature
indicates that elevated levels of androgens cause cell quiescence in fibroblasts (43). While this may seem contradictory
to the current findings, they instead help narrow the possibilities of what is taking place. The cell may very well be
prioritizing proliferation but failing to divide. These relationships merit further exploration.
Conclusion:
This study provided a needed in vitro model for studying the relationship between PFD in PCOS women. The
isolation of fibroblasts helped confirm their presence in these tissues, and immunostaining helped elucidate their
localization. Treatment of cells with E2, T, and DHT showed that AR reduces collagen production and causes
prioritization of intracellular function over ECM deposition in fibroblasts.
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